Key Points Big pharma companies are jostling for position in the weight loss market. A larger pharma company may decide it's worth taking Viking's promising drug candidate through phase 3. 10 stocks we like better than Viking Therapeutics › Shares in Viking Therapeutics (NASDAQ: VKTX) were up more than 16% in the week to Thursday at 1 pm. The move comes after the announcement of another acquisition of a small-cap biopharmaceutical company by a pharmaceutical giant. This time, it's Novo Nordisk payi ...

Novo CEO’s First Test is Winning Back the US Weight Loss Market https://t.co/lqhTjQEFmq ...

It's not too often that pharmaceutical drugs become household names, but that's happening with medicines in the weight loss market. Brands such as Wegovy and Zepbound -- the leading anti-obesity therapies -- are now well known and are generating billions of dollars in annual sales. That's why other drugmakers want to dip their toes in this lucrative and high-growth market.AbbVie (ABBV 1.68%) is one of them. The company, best known for its work in immunology, recently made a move to enter the weight loss spa ...